Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Law Bytes Podcast, Episode 267: Peter Nowak on Rogers, the Shaw Merger Aftermath, and the Limits of Canadian Telecom Policy 
Going Through the Motions: How Parliament Is Shutting Down Study and Debate on Political Party Privacy 
Why The Senate Got Antisemitism Only Half-Right 
The Government Doubles Down on News Sector Support: Fiscal Update Opens the Door to Tens of Millions in Tax Credits for Bell, Rogers and Corus 
The Illusion of Protection: Why Canada’s Growing Push to Ban Social Media for Kids Won’t Work
